Job Creations
Filter News
Found 5,074 articles
-
Though the world is reopening, this pandemic is not over. Moderna continues expanding production to answer the call globally.
-
The new U.S. HQ for Neogene has the backing of biotech guru Arie Belldegrun, CEO of Kite Pharma. The company has leased 38,000 sq. ft. in two Santa Monica buildings.
-
Moderna Reaffirms Commitment to Job Creation in Massachusetts
6/18/2021
Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines, reaffirmed its commitment to job creation in Massachusetts.
-
The company, which isn’t expected to enter the clinic until possibly in 2022, is working to make cell therapies work in solid tumors.
-
The additional 100 people will be placed in Seattle, San Francisco, and Cambridge, Mass. by the end of the year.
-
CARsgen is building a new $157 million CAR-T manufacturing facility in Durham, that is expected to create approximately 200 new jobs.
-
Thermo Fisher Plans Cell Therapy Manufacturing Site in Bay Area; Pfizer Expands Irish Plant
5/19/2021
Thermo Fisher and the University of California partnered with the development and manufacturing of cell-based therapies with the construction of its 44,000 sq. ft. manufacturing facility. -
Landos Biopharma partnered with Shanghai, China-based LianBio to develop and commercialize omilancor and NX-13 in Greater China and select Asian markets.
-
The help wanted signs are up across the biopharma industry. Companies are opening and expanding facilities, which is good news for job seekers.
-
Life science jobs are booming in several regions around the U.S. One is the Pacific Northwest, specifically Oregon; another is the Philadelphia area. Here’s a look.
-
Significant contributions were made to the Series A by Boxer Capital, Nextech Invest, Casdin Capital, Invus Financial Advisors, and Eventide Asset Management.
-
BioNTech will open a state-of-the-art manufacturing facility in Singapore to support a global supply of mRNA-based vaccines and therapeutics.
-
Since emerging from stealth mode in 2020 Dyno Therapeutics has been busy advancing its gene therapy platform. This morning, the company bolsters its research with $100 million raised in a Series A financing round.
-
Fueled by billions of dollars invested by the federal government to battle the ongoing COVID-19 pandemic, companies across the BioCapital region have expanded their footprint and number of employees.
-
Work-at-home arrangements created to respond to the COVID-19 pandemic have forced numerous companies in most sectors to reevaluate their work deals. This has also resulted in rethinking site locations and real estate needs. Here’s a look.
-
COVID-19 Brief: Atea Initiates Phase III for Investigational Antiviral, BioNTech Tests Vaccine in...
4/29/2021
The battle against COVID-19 rages on, and other therapeutics are making their way through the clinic, including monoclonal antibody treatments and antivirals. BioSpace takes a look at some of the ongoing efforts to stem the rate of infection from the virus. -
Abzena is opening another manufacturing site, its sixth in a global network. This morning, the partner research organization announced it would build a $200 million facility in Sanford, N.C.
-
Aran Biomedical Expansion: Galway Implantable Device Manufacturer to create 150 New Jobs
4/12/2021
In response to growing business demand, Aran Biomedical Teoranta, a leading biomaterials contract manufacturer of proprietary medical devices, announced the creation of 150 new jobs over 3 years.
-
Pfizer announced plans to create a professional services office in Tampa, Florida. It will be located in more than 100,000 square feet of office space and believe they will be generating hundreds of new jobs.
-
Here’s a recap of companies announcing facility expansions this past month and life sciences job creations across the nation.